Best of Hematology & Breast Cancer™ 2026, Portland
Accreditation: 8.50 Nursing Contact Hours | 8.50 AMA PRA Category 1 Credit™ | 8.50 ABIM MOC II | 8.50 ACPE Pharmacy
Venue: Embassy Suites by Hilton Portland Downtown , 319 Southwest Pine Street, Portland, OR, United States
Official conference page for Best of Hematology & Breast Cancer™ 2026, Portland. https://binaytara.org/projects/conferences/best-of-hematology-breast-cancer-2026-portland
About Best of Hematology & Breast Cancer™ 2026, Portland


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Day 1: Friday, February 6th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
Session Chair: Joseph James Shatzel, MD
03:00 PM - 03:15 PM
HUS/TTP – Kylee Martens, MD
03:15 PM - 03:30 PM
PNH – Daniel Guy, MD, MD
03:30 PM - 03:45 PM
Anemia – Joseph James Shatzel, MD
03:45 PM - 04:00 PM
Bone Marrow Failure – Tsewang Tashi, MD
Session Chair: Doris Quon, MD, PhD
04:00 PM - 04:20 PM
Bleeding Disorders – Kylee Martens, MD
04:20 PM - 04:40 PM
Clotting Disorders – Joseph James Shatzel, MD
04:40 PM - 05:00 PM
Case-Based Discussion
Day 2: Saturday, February 7th, 2026
Conference Chair: Matt Lambert, n/a
Session Chair: Ronan Swords, MD
08:30 AM - 09:00 AM
Acute Myeloid Leukemia/MDS – Curtis Andrew Lachowiez, MD
09:00 AM - 09:30 AM
Acute Lymphoblastic Leukemia – Jessica Leonard, MD
Session Chair: Natasha C Edwin, MD
09:30 AM - 10:00 AM
Updates in Lymphoma – Mengyang Di, MD, PhD
10:00 AM - 10:30 AM
CLL – Stephen Spurgeon, MD
Session Chair: Natasha C Edwin, MD
11:00 AM - 11:30 AM
Frontline Therapy of Multiple Myeloma – Eva Medvedova, MD
11:30 AM - 12:00 PM
Relapsed/Recurrent Multiple Myeloma – Rebecca Silbermann, MD
Session Chair: Theodore Paul Braun, MD, PhD
01:00 PM - 01:30 PM
Myeloproliferative Neoplasms – Elie Traer, MD
01:30 PM - 02:00 PM
Cellular Therapy – Arpita Gandhi, MD
Venue and map
Accreditations and continuing education
Acknowledgement of Commerical Support
This activity is supported with Independent Medical Education grants from:
- Gilead
- Stemline Therapeutics, Inc
